Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1990 | 3 |
1991 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Synthesis and in vivo antitumor activity of 2-amino-9H-purine-6-sulfenamide, -sulfinamide, and -sulfonamide and related purine ribonucleosides.
J Med Chem. 1990 Jan;33(1):121-8. doi: 10.1021/jm00163a020.
J Med Chem. 1990.
PMID: 2296010
However, oxidation of 8a and 8b with excess of MCPBA gave 9-beta-D-ribofuranosylpurine-6-sulfonamide (10a) and 2-amino-9-beta-D-ribofuranosylpurine-6-sulfonamide (sulfonosine, 10b), respectively. Similarly, amination of 5'-deoxy-6-thioguanosine (7c) afforded the 6-sulfenam …
However, oxidation of 8a and 8b with excess of MCPBA gave 9-beta-D-ribofuranosylpurine-6-sulfonamide (10a) and 2-amino-9-beta-D-ribofuranosy …
Synthesis and antitumor evaluation in mice of certain 7-deazapurine (pyrrolo[2,3-d]pyrimidine) and 3-deazapurine (imidazo[4,5-c]pyridine) nucleosides structurally related to sulfenosine, sulfinosine, and sulfonosine.
Ramasamy K, Imamura N, Hanna NB, Finch RA, Avery TL, Robins RK, Revankar GR.
Ramasamy K, et al.
J Med Chem. 1990 Apr;33(4):1220-5. doi: 10.1021/jm00166a021.
J Med Chem. 1990.
PMID: 2319564
7-Deaza (pyrrolo[2,3-d]pyrimidine) and 3-deaza (imidazo[4,5-c]pyridine) congeners of sulfenosine (5a and 9), sulfinosine (6a and 10), and sulfonosine (7a) have been prepared and evaluated for their antileukemic activity in mice. ...
7-Deaza (pyrrolo[2,3-d]pyrimidine) and 3-deaza (imidazo[4,5-c]pyridine) congeners of sulfenosine (5a and 9), sulfinosine (6a and 10), and …
Item in Clipboard
Oxidation of 2-amino-9-beta-D-ribofuranosylpurine-6-sulfenamide to the corresponding 6-sulfonamide facilitates changes in biologic characterization that include activity against thiopurine-refractory experimental leukemia.
Finch RA, Vasquez KM, Hanna NB, Revankar GR, Robins RK, Avery TL.
Finch RA, et al.
Cancer Lett. 1990 Apr 9;50(1):63-70. doi: 10.1016/0304-3835(90)90180-6.
Cancer Lett. 1990.
PMID: 2322928
Preclinical investigations in vivo revealed unexpected differences in the biological characteristics of 2-amino-9-beta-D-ribofuranosylpurine-6-sulfenamide (sulfenosine, 1) and 2-amino-9-beta-D-ribofuranosylpurine-6-sulfonamide (sulfonosine, 2), two novel but structurally r …
Preclinical investigations in vivo revealed unexpected differences in the biological characteristics of 2-amino-9-beta-D-ribofuranosylpurine …
Item in Clipboard
Analysis of the in vitro antitumor activity of novel purine-6-sulfenamide, -sulfinamide, and -sulfonamide nucleosides and certain related compounds using a computer-aided receptor modeling procedure.
Viswanadhan VN, Ghose AK, Hanna NB, Matsumoto SS, Avery TL, Revankar GR, Robins RK.
Viswanadhan VN, et al.
J Med Chem. 1991 Feb;34(2):526-32. doi: 10.1021/jm00106a007.
J Med Chem. 1991.
PMID: 1995873
Item in Clipboard
Cite
Cite